Skip to Content

Caprelsa Prices, Coupons and Patient Assistance Programs

Caprelsa (vandetanib) is a member of the EGFR inhibitors drug class and is commonly used for Thyroid Cancer.

Caprelsa Prices

This Caprelsa price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies. The cost for Caprelsa oral tablet 100 mg is around $6,727 for a supply of 30 tablets, depending on the pharmacy you visit. Prices are for cash paying customers only and are not valid with insurance plans.

Caprelsa is available as a brand name drug only, a generic version is not yet available. For more information, read about generic Caprelsa availability.

Oral Tablet

100 mg Caprelsa oral tablet
from $6,727.33 for 30 tablet
Quantity Per unit Price
30 $224.24 $6,727.33

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

300 mg Caprelsa oral tablet
from $13,446.08 for 30 tablet
Quantity Per unit Price
30 $448.20 $13,446.08

Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.

Drugs.com Printable Discount Card

Print Now

The free Drugs.com Discount Card works like a coupon and can save you up to 80% or more off the cost of prescription medicines, over-the-counter drugs and pet prescriptions.

Please note: This is a drug discount program, not an insurance plan. Valid at all major chains including Walgreens, CVS Pharmacy, Target, WalMart Pharmacy, Duane Reade and 63,000 pharmacies nationwide.


Caprelsa Coupons and Rebates

Caprelsa offers may be in the form of a printable coupon, rebate, savings card, trial offer, or free samples. Some offers may be printed right from a website, others require registration, completing a questionnaire, or obtaining a sample from the doctor's office.

Caprelsa Co-Pay Assistance Program: Eligible commercially patients may save up to $20,000 on out-of-pocket costs per calendar year; for additional information contact the program 800-367-4999.

Applies to:Caprelsa
Number of uses:Per prescription until program expires

Caprelsa Interim Access Program: Eligible uninsured patients may be able to receive a short term supply of Caprelsa FREE of charge; must be medically and in financially need; for additional information contact the program at 800-367-4999.

Applies to:Caprelsa
Number of uses:Per prescription until program expires

Patient Assistance Programs for Caprelsa

Patient assistance programs (PAPs) are usually sponsored by pharmaceutical companies and provide free or discounted medicines to low income or uninsured and under-insured people who meet specific guidelines. Eligibility requirements vary for each program.

Provider: Patient Access Network Foundation (PAN)

Elligibility requirements:

  1. *See Additional Information section below
  2. Between 400-500% of FPL
  3. Medically appropriate condition/diagnosis
  4. Must reside and receive treatment in US
  5. *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.

Applicable drugs:

  • Caprelsa (vandetanib)

Provider: Good Days Program

Elligibility requirements:

  1. Not specified
  2. Not disclosed
  3. Not specified
  4. US residency requirements are not specified.
  5. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly.

Applicable drugs:

  • Caprelsa (vandetanib)

Provider: Caprelsa Patient Assistance Program

Elligibility requirements:

  1. Uninsured or Underinsured
  2. Not disclosed
  3. FDA-approved diagnosis
  4. The patient must be a US citizen or legal resident.
  5. Prescribing Physician, Healthcare Facilities, Pharmacies and Patients must enroll into the Risk Evaluation and Mitigation Strategy (REMS) Program prior to initiating the patient on treatment with Caprelsa. Contact program for more detail.

Applicable drugs:

  • Caprelsa (vandetanib)
Hide